|
1）Kakizuka A. Roles of VCP in human neurodegenerative disorders. Biochem Soc Trans. 2008; 36(Pt 1): 105-8
|
|
|
|
2）Meyer H, Bug M, Bremer S. Emerging functions of the VCP/p97 AAA-ATPase in the ubiquitin system. Nat Cell Biol. 2012; 14: 117-23
|
|
|
|
|
|
3）Ju JS, Fuentealba RA, Miller SE, et al. Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease. J Cell Biol. 2009; 187: 875-88
|
|
|
|
|
|
4）Krick R, Bremer S, Welter E, et al. Cdc48/p97 and Shp1/p47 regulate autophagosome biogenesis in concert with ubiquitin-like Atg8. J Cell Biol. 2010; 190: 965-73
|
|
|
|
|
|
5）Watts GD, Wymer J, Kovach MJ, et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet. 2004; 36: 377-81
|
|
|
|
|
|
6）Johnson JO, Mandrioli J, Benatar M, et al. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron. 2010; 68: 857-64
|
|
|
|
|
|
7）Tang WK, Li D, Li CC, et al. A novel ATP-dependent conformation in p97 N-D1 fragment revealed by crystal structures of disease-related mutants. EMBO J. 2010; 29: 2217-29
|
|
|
|
|
|
8）Takata T, Kimura Y, Ohnuma Y, et al. Rescue of growth defects of yeast cdc48 mutants by pathogenic IBMPFD-VCPs. J Struct Biol. 2012; 179: 93-103
|
|
|
|
|
|
9）Buchan JR, Kolaitis RM, Taylor JP, et al. Eukaryotic stress granules are cleared by autophagy and Cdc48/VCP function. Cell. 2013; 153: 1461-74
|
|
|
|
|
|
10）Narendra D, Tanaka A, Suen DF, et al, Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol. 2008; 183: 795-803
|
|
|
|
|
|
11）尾勝 圭，松田憲之．Parkin ユビキチンリガーゼとミトコンドリアの品質管理．医学のあゆみ．2012; 243: 530-4
|
|
|
|
|
12）Kim NC, Tresse E, Kolaitis RM, et al. VCP is essential for mitochondrial quality control by PINK1/Parkin and this function is impaired by VCP mutations. Neuron. 2013; 78: 65-80
|
|
|
|
|
|
13）Kimura Y, Fukushi J, Hori H, et al. Different dynamic movements of wild-type and pathogenic VCPs and their cofactors to damaged mitochondria in a Parkin-mediated mitochondrial quality control system. Genes Cells. 2013. In press
|
|
|
|
|
|
14）Elden AC, Kim HJ, Hart MP, et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature. 2010; 466: 1069-75
|
|
|
|
|
|
15）Lee BH, Lee MJ, Park S, et al, Enhancement of proteasome activity by a small-molecule inhibitor of USP14. Nature. 2010; 467: 179-84
|
|
|
|
|
|
16）Arai T, Hasegawa M, Akiyama H, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2006; 351: 602-11
|
|
|
|
|
|
17）Li YR, King OD, Shorter J, et al. Stress granules as crucibles of ALS pathogenesis. J Cell Biol. 2013; 201: 361-72
|
|
|
|
|
|
18）Ramaswami M, Taylor JP, Parker R. Altered ribostasis: RNA-protein granules in degenerative disorders. Cell. 2013; 154: 727-36
|
|
|
|
|
|
19）Kim HJ, Kim NC, Wang YD, et al. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature. 2013; 495: 467-73
|
|
|
|
|
|
20）Polymenidou M, Cleveland DW. The seeds of neurodegeneration: prion-like spreading in ALS. Cell. 2011; 147: 498-508
|
|
|
|
|
|
21）Nonaka T, Masuda-Suzukake M, Arai T, et al. Prion-like properties of pathological TDP-43 aggregates from diseased brains. Cell Rep. 2013; 4: 124-34
|
|
|
|
|